Europe debating how to regulate emerging genome editing technology

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.

EU policymakers are about to embark on a process which will go a long way to shaping the future of plant breeding in Europe – and whether EU farmers will be able to benefit from an emerging new technology.

After years of contemplation, the European Commission is expected to publish soon, possibly by the end of October, its opinion on how the relatively new technology, genome editing, should be classified and regulated.

This will kick-start a process which will eventually determine whether crops created by the technology, or at least strands of it, should be classified as genetically modified organisms (GMOs).

Genome editing involves inserting pieces of DNA, known as ‘molecular scissors’ into a host plant to cut and alter the genome of the host plant. In its simplest form, the technology deletes or alters existing genes without introducing new DNA.

Prof Huw Jones, of Rothamsted Research, Hertfordshire, said genome editing had the potential to revolutionise plant breeding in Europe, but only if policymakers treat it fairly.

He said: “If it is seen as a non-GMO, it will streamline the approval process and could change how plant breeding is done.

“If it is seen as a GMO…All the subsequent negativity surrounding GM would effectively prevent them being used in Europe.”

Penny Maplestone, chief executive of the British Society of Plant Breeders, said: “How the technology develops from here is completely dependent on what happens in the regulatory world.

The environmental lobby sees things differently. Various non-Governmental organisations have already joined forces to oppose the new technology and demand it is regulated as GM.

Read full, original post: GM or not GM? Why key decisions on new technology will shape EU plant breeding

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-04-22-at-12.21.32-PM
Viewpoint: Why the retracted Monsanto glyphosate study doesn’t change the science—the world’s most popular herbicide is safe 
ChatGPT-Image-Apr-16-2026-02_56_53-PM
Financial incentives, over diagnosis, and weak oversight: Autism claims are driving up Medicare costs
Picture1
The FDA couldn’t find a vaccine safety crisis, so it buried its own research
ChatGPT-Image-May-1-2026-11_42_59-AM-2
Viewpoint: NAD is the wellness grifters latest evidence-lite longevity fad. At least the mice are impressed.
Screenshot-2026-05-21-at-12.15.17-PM
UK gene-editing milestone: Livestock barley that increases ruminant value and reduces methane emissions is first-approved CRISPR crop
global warming
‘Implausible’: Top climate scientists reject worst-case scenario—soaring temperatures and fast-rising sea levels
Screenshot-2026-05-21-at-3.15.53-PM
Chiropractors may no longer be modern-day snake oil salesmen, but the benefits of their therapy are limited–at best

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.